Corvus Pharmaceuticals, Inc. (CRVS)
NASDAQ: CRVS · Real-Time Price · USD
7.53
-0.11 (-1.44%)
Nov 5, 2025, 4:00 PM EST - Market closed
Corvus Pharmaceuticals Market Cap
Corvus Pharmaceuticals has a market cap or net worth of $562.35 million as of November 5, 2025. Its market cap has increased by 18.92% in one year.
Market Cap
562.35M
Enterprise Value
497.68M
1-Year Change
18.92%
Ranking
Category
Stock Price
$7.53
Market Cap Chart
Since March 23, 2016, Corvus Pharmaceuticals's market cap has increased from $290.80M to $562.35M, an increase of 93.38%. That is a compound annual growth rate of 7.09%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 5, 2025 | 561.10M | 63.21% |
| Dec 31, 2024 | 343.80M | 298.38% |
| Dec 29, 2023 | 86.30M | 117.93% |
| Dec 30, 2022 | 39.60M | -64.71% |
| Dec 31, 2021 | 112.20M | 12.31% |
| Dec 31, 2020 | 99.90M | -37.56% |
| Dec 31, 2019 | 160.00M | 48.84% |
| Dec 31, 2018 | 107.50M | -50.69% |
| Dec 29, 2017 | 218.00M | -27.09% |
| Dec 30, 2016 | 299.00M | 2.82% |
| Mar 23, 2016 | 290.80M | - |
View and export this data all the way back to 2016. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 828.96B |
| Johnson & Johnson | 448.13B |
| AbbVie | 383.12B |
| UnitedHealth Group | 296.88B |
| AstraZeneca | 251.76B |
| Novartis AG | 240.29B |
| Abbott Laboratories | 216.56B |
| Thermo Fisher Scientific | 213.27B |